OncoImmunology
Volume 9, 2020 - Issue 1
Brief Report
Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model
, , , , , 
, & show all
Louis Boond Bioceros, Utrecht, The Netherlandshttps://orcid.org/0000-0002-0937-9171View further author information
https://orcid.org/0000-0002-0937-9171View further author information, Peter M. Hoogerbruggee Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlandshttps://orcid.org/0000-0003-3012-6109View further author information
https://orcid.org/0000-0003-3012-6109View further author information & Gosse J Ademaa Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-6750-1665View further author information
https://orcid.org/0000-0002-6750-1665View further author information show all